Archives for paul@extractmg.com
With the revised Annex 1 coming into effect last year, the pharmaceutical industry continues to strategize the best way to attain and maintain compliance with the intensive regulation on sterile medicinal products. Aseptic fill-finish manufacturing, for its part, is established on precise science and the highest standards of safety. While much of the science, technology, […]
Josh Russell, Vice President of Sales and Marketing, recently spoke to American Pharmaceutical Review on ASTâs latest aseptic processing solutions. American Pharmaceutical Review, a leading journal for business and technology, connected with Josh at Interphex 2024, where AST exhibited our latest generation GENiSYSÂŽ C housed inside ASTâs new isolator solution. The exhibit showcased the latest […]
Josh Russell, ASTâs Vice President of Sales and Marketing, recently took part in the Virtual Pharma Expo: Aseptic Fill/Finish, Manufacturing and Packaging with a walkthrough of some of the latest AST technology, demonstrated on our GENiSYSÂŽ R robotic line.Â
ASTâs Director of Engineering Spencer Bolte walks through some of the key design considerations on ASTâs new isolator including operator-centered solutions and a groundbreaking new decontamination technology for complete 60-minute cycle times, including aeration. The newly unveiled AST isolator and the latest generation GENiSYS C are two of ASTâs intuitive, compact solutions for high-value liquid […]
AST CTO and VP of Customer Service Steven Ng recently connected with Cleanroom Technology for an extended discussion on ASTâs new isolator solution. Steven gives an inside look at ASTâs engineering approach, the key collaborations with Germfree and CURIS System, and considers how the numerous advancements integrated into this new barrier technology will help move […]
For pharmaceutical manufacturers, every endeavor into drug development comes with a measure of uncertainty and unpredictability. Itâs important to have a plan in place for when the need for adaptability arises, and that leaves many looking into proven ways to incorporate flexibility into their operational strategy. Additionally, trends in aseptic fill-finish manufacturing show customers are […]
Pharmaceutical manufacturing continues to see growth in the field of highly targeted, high-value liquid pharmaceuticals. Increasingly, entities like CDMOs, are looking at the most effective ways to implement adaptable, streamlined multi-modal operations designed for uptime and time-to-market optimization. In the initial phases of planning your aseptic fill-finish operation, there are many decisions to make both […]
Meet two of the innovative minds that helped lead the AST-Germfree collaboration on next-generation barrier technology: Engineers Michael Moore (AST) and Paula Rizo (Germfree) connected at Interphex to discuss what sets this isolator solution apart and what the journey over the course of this collaboration has been like for the two teams. At Interphex 2024, AST was thrilled to […]
The following article is part 2 of a blog series that has been adapted from ASTâs VP of Sales and Marketing Josh Russellâs recent article in Cleanroom Technology. In part 1, we discussed considerations for isolator configurations and ASTâs approach to integrating automation in our new barrier technology solution. The most important questions to consider […]
The following 2-part blog series has been adapted from ASTâs VP of Sales and Marketing Josh Russellâs recent article in Cleanroom Technology.